Kidney Biopsy

A kidney biopsy is a procedure that involves taking a small piece of kidney tissue for examination with a microscope. The test helps your doctor identify the type of kidney disease you have, how severe it is, and the best treatment for it.

Webinars

FEB 21, 2023 | 10:00 AM

C.E. CREDITS

Cystatin C and Race-free GFR Estimation: Evaluating both clinical...

Date: February 21, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) The use of algorithms that alter patient medical care based on race has fallen under increasing criticism, as race-bas...

Speaker: Amy Karger, MD, PhD , O. Alison Potok, MD

Sponsored By: Siemens Healthineers

12

JUN 30, 2022 | 9:00 AM

The PCR Advantage: How the Biomark™ HD System Enhances the TruGraf®...

Date: June 30, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Subclinical acute rejection (SubAR) is a significant risk for kidney transplant recipients, affecting 1 in 4 patients. Ea...

Speaker: Juston Weems, Ph.D.

Sponsored By: Standard BioTools

8

OCT 10, 2019 | 9:00 AM

Next Generation Targets for Immuno-Oncology

Blockade of CTLA-4 and PD-1, members of the B7/CD28 family, have proven to be the most successful cancer immunotherapies to date. While the current therapeutic focus remains on B7/CD28 family...

Speaker: Anthony Persen, PhD

Presented at: Cancer Research & Oncology Week Virtual Event Series 2019
Sponsored By: ACD - A Bio-Techne Brand

1

SEP 30, 2015 | 10:30 AM

The Evolving Role of Image-Guided Prostate Cancer Targeting and...

The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...

Speaker: Rajan Gupta, MD , Thomas Polascik, MD , Stacy Loeb, MD

Presented at: Cancer Research & Oncology Week Virtual Event Series 2015

0

FEB 21, 2023 | 10:00 AM

C.E. CREDITS

Cystatin C and Race-free GFR Estimation: Evaluating both clinical...

Date: February 21, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) The use of algorithms that alter patient medical care based on race has fallen under increasing criticism, as race-bas...

Speaker: Amy Karger, MD, PhD , O. Alison Potok, MD

Sponsored By: Siemens Healthineers

JUN 30, 2022 | 9:00 AM

The PCR Advantage: How the Biomark™ HD System Enhances the TruGraf®...

Date: June 30, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Subclinical acute rejection (SubAR) is a significant risk for kidney transplant recipients, affecting 1 in 4 patients. Ea...

Speaker: Juston Weems, Ph.D.

Sponsored By: Standard BioTools

OCT 10, 2019 | 9:00 AM

Next Generation Targets for Immuno-Oncology

Blockade of CTLA-4 and PD-1, members of the B7/CD28 family, have proven to be the most successful cancer immunotherapies to date. While the current therapeutic focus remains on B7/CD28 family...

Speaker: Anthony Persen, PhD

Presented at: Cancer Research & Oncology Week Virtual Event Series 2019
Sponsored By: ACD - A Bio-Techne Brand

SEP 30, 2015 | 10:30 AM

The Evolving Role of Image-Guided Prostate Cancer Targeting and...

The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...

Speaker: Rajan Gupta, MD , Thomas Polascik, MD , Stacy Loeb, MD

Presented at: Cancer Research & Oncology Week Virtual Event Series 2015

Related Tags